Reich Samuel J

Reich Samuel J is listed in filings as CEO at SAB Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 5, 2026, including 3 public disclosures. Recent filings connect the profile to SAB Biotherapeutics, Inc. (SABS). The current snapshot covers public activity from Jul 17, 2024 to Feb 5, 2026. Reported amounts are shown as $21.4M to $103.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.